INS and type 1 diabetes mellitus: Given that some therapeutic approaches that improve the insulin sensitivity of skeletal muscle have been shown to improve glycaemic control and potentially decelerate T1DM disease progression [18, 19], skeletal muscle changes in T1DM have recently become a focal point of both pathophysiological and therapeutic research [13].